Clinical Trials List
2024-03-01 - 2030-07-16
Phase III
Recruiting10
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- ZHENG-WEI ZHOU 無
- 鄧齡喬 無
- CHENG-HSIEN LIN 無
- PO-HSIEN LI 無
- 滕傑林 無
- Chieh-Lin Teng 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李思慧 無
- HSIN-AN HOU 無
- Chieh-Lung Cheng 無
- Wen-Chien Chou 無
- MING YAO 無
- Huai-Hsuan Huang 無
- MEI-FANG CHENG 無
- 林明恩 無
- YAO CHI-YUAN 無
- 劉高郎 無
- 田豐銘 無
- Chien-Chin Lin 無
- - - 無
- CHENG-HONG TSAI 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林潔 無
- 王元欽 無
- Ming-Chung Kao 無
- Tung-Liang Lin 無
- 陳建誠 無
- 蘇羿囷 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王秀慈 無
- Wei-Ching Lin 無
- 陳珈妤 無
- 王幸婷 無
- Ming-Yu Lien 無
- Che-Hung Lin 無
- Chi-Ching Chen 無
- 鄭富銘 無
- Ching-Chan Lin 無
- Tzu-Ting Chen 無
- Ching Yun Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
850 participants
